Martínez-Yélamos S - Search Results

1

Anticipation of age at onset in multiple sclerosis: methodologic pitfalls.

Alonso-Magdalena L, Romero-Pinel L, Moral E, Carmona O, Gubieras L, Ramón JM, Martínez-Yélamos S, Arbizu T. Alonso-Magdalena L, et al. Acta Neurol Scand. 2010 Jun;121(6):426-8. doi: 10.1111/j.1600-0404.2009.01273.x. Acta Neurol Scand. 2010. PMID: 20578997

2

Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases.

Muñoz-Vendrell A, Tena-Cucala R, Campoy S, García-Parra B, Prat J, Martínez-Yélamos S, Huerta-Villanueva M. Muñoz-Vendrell A, et al. Headache. 2023 Apr;63(4):559-564. doi: 10.1111/head.14505. Epub 2023 Apr 10. Headache. 2023. PMID: 37036126 Free article.

3

CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS.

Martínez-Yélamos A, Rovira A, Sánchez-Valle R, Martínez-Yélamos S, Tintoré M, Blanco Y, Graus F, Montalban X, Arbizu T, Saiz A. Martínez-Yélamos A, et al. J Neurol. 2004 Oct;251(10):1278-9. doi: 10.1007/s00415-004-0524-y. J Neurol. 2004. PMID: 15503113 No abstract available.

4

Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases.

Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, Rubio F, Arbizu T. Bruna J, et al. Mult Scler. 2006 Apr;12(2):169-73. doi: 10.1191/135248506ms1260oa. Mult Scler. 2006. PMID: 16629419

5

[The costs of a multiple sclerosis relapse in Catalonia (Spain)].

Casado V, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Alonso L, Romero L, Moral E, Arbizu T. Casado V, et al. Neurologia. 2006 Sep;21(7):341-7. Neurologia. 2006. PMID: 16977554 Spanish.

6

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.

Casado V, Martínez-Yélamos S, Martínez-Yélamos A, Carmona O, Alonso L, Romero L, Moral E, Gubieras L, Arbizu T. Casado V, et al. BMC Health Serv Res. 2006 Nov 1;6:143. doi: 10.1186/1472-6963-6-143. BMC Health Serv Res. 2006. PMID: 17078879 Free PMC article.

7

Regression to the mean in multiple sclerosis.

Martínez-Yélamos S, Martínez-Yélamos A, Martín Ozaeta G, Casado V, Carmona O, Arbizu T. Martínez-Yélamos S, et al. Mult Scler. 2006 Dec;12(6):826-9. doi: 10.1177/1352458506070820. Mult Scler. 2006. PMID: 17263014

8

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.

Casado V, Romero L, Gubieras L, Alonso L, Moral E, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Arbizu T. Casado V, et al. Mult Scler. 2007 Jul;13(6):800-4. doi: 10.1177/1352458506073480. Epub 2007 Mar 15. Mult Scler. 2007. PMID: 17613609

9

Interferon-beta1b in multiple sclerosis: effect on progression of disability and clinical markers of treatment response.

Carmona O, Casado V, Moral E, Alonso-Magdalena L, Martínez-Yélamos A, Martínez-Yélamos S, Martín-Ozaeta G, Arbizu T. Carmona O, et al. Eur Neurol. 2008;60(6):279-84. doi: 10.1159/000157881. Epub 2008 Sep 27. Eur Neurol. 2008. PMID: 18824855 Clinical Trial.

10

Anticipation of age at onset in familial multiple sclerosis.

Romero-Pinel L, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Kremenchutzky M, Arbizu T. Romero-Pinel L, et al. Eur J Neurol. 2010 Apr;17(4):572-5. doi: 10.1111/j.1468-1331.2009.02870.x. Epub 2009 Dec 7. Eur J Neurol. 2010. PMID: 20002735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters